BACKGROUND: The contribution of IL-1beta signaling through the IL-1 type 1 receptor (IL-1R1) to the development of persistent LPS-induced airway disease has not been investigated. OBJECTIVE: To determine the importance of signaling through the IL-1 type 1 receptor in the development of LPS-induced airway disease. METHODS: We exposed IL-1R1-deficient (C57BL/6(IL-1RI-/-)) mice to an aerosol of LPS or filtered air for 1 day, 1 week, or 4 weeks. RESULTS: After 4 weeks of LPS inhalation, C57BL/6(IL-1RI-/-) mice failed to develop significant submucosal thickening, whereas C57BL/6 mice had significantly thickened submucosa in small, medium, and large airways compared with those of unexposed control mice. Cell proliferation in the airways of both the 1-week and 4-week LPS-exposed C57BL/6(IL-1RI-/-) mice was significantly reduced compared with LPS-exposed C57BL/6 mice. mRNA for type III alpha-3 procollagen was significantly elevated over baseline in C57BL/6 yet remained unchanged compared with baseline in C57BL/6(IL-1RI-/-) mice after 1 week or 4 weeks of LPS inhalation. mRNA for tissue inhibitor of metalloprotease 1 in C57BL/6 mice in the 1-week and 4-week groups was significantly elevated over both control mice and C57BL/6(IL-1RI-/-) mice. CONCLUSION: These data support the hypothesis that signaling through the IL-1 receptor modulates extracellular matrix homeostasis in response to inhaled LPS. CLINICAL IMPLICATIONS: Attenuating IL-1R1-mediated signaling might be an effective therapy against the development of airway remodeling in chronic inflammatory diseases.
BACKGROUND: The contribution of IL-1beta signaling through the IL-1 type 1 receptor (IL-1R1) to the development of persistent LPS-induced airway disease has not been investigated. OBJECTIVE: To determine the importance of signaling through the IL-1 type 1 receptor in the development of LPS-induced airway disease. METHODS: We exposed IL-1R1-deficient (C57BL/6(IL-1RI-/-)) mice to an aerosol of LPS or filtered air for 1 day, 1 week, or 4 weeks. RESULTS: After 4 weeks of LPS inhalation, C57BL/6(IL-1RI-/-) mice failed to develop significant submucosal thickening, whereas C57BL/6 mice had significantly thickened submucosa in small, medium, and large airways compared with those of unexposed control mice. Cell proliferation in the airways of both the 1-week and 4-week LPS-exposed C57BL/6(IL-1RI-/-) mice was significantly reduced compared with LPS-exposed C57BL/6 mice. mRNA for type III alpha-3 procollagen was significantly elevated over baseline in C57BL/6 yet remained unchanged compared with baseline in C57BL/6(IL-1RI-/-) mice after 1 week or 4 weeks of LPS inhalation. mRNA for tissue inhibitor of metalloprotease 1 in C57BL/6 mice in the 1-week and 4-week groups was significantly elevated over both control mice and C57BL/6(IL-1RI-/-) mice. CONCLUSION: These data support the hypothesis that signaling through the IL-1 receptor modulates extracellular matrix homeostasis in response to inhaled LPS. CLINICAL IMPLICATIONS: Attenuating IL-1R1-mediated signaling might be an effective therapy against the development of airway remodeling in chronic inflammatory diseases.
Authors: C L George; H Jin; C L Wohlford-Lenane; M E O'Neill; J C Phipps; P O'Shaughnessy; J N Kline; P S Thorne; D A Schwartz Journal: Am J Physiol Lung Cell Mol Physiol Date: 2001-02 Impact factor: 5.464
Authors: A Poltorak; I Smirnova; X He; M Y Liu; C Van Huffel; O McNally; D Birdwell; E Alejos; M Silva; X Du; P Thompson; E K Chan; J Ledesma; B Roe; S Clifton; S N Vogel; B Beutler Journal: Blood Cells Mol Dis Date: 1998-09 Impact factor: 3.039
Authors: F X Zhang; C J Kirschning; R Mancinelli; X P Xu; Y Jin; E Faure; A Mantovani; M Rothe; M Muzio; M Arditi Journal: J Biol Chem Date: 1999-03-19 Impact factor: 5.157
Authors: A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler Journal: Science Date: 1998-12-11 Impact factor: 47.728
Authors: Jordan D Savov; David M Brass; Katherine G Berman; Erin McElvania; David A Schwartz Journal: Am J Physiol Lung Cell Mol Physiol Date: 2003-06-20 Impact factor: 5.464
Authors: D M Brass; J D Savov; S H Gavett; N Haykal-Coates; D A Schwartz Journal: Am J Physiol Lung Cell Mol Physiol Date: 2003-06-06 Impact factor: 5.464
Authors: Kristin M Hudock; Yuhong Liu; Junjie Mei; Roberta C Marino; Jason E Hale; Ning Dai; G Scott Worthen Journal: Am J Respir Cell Mol Biol Date: 2012-05-16 Impact factor: 6.914
Authors: Jill A Poole; Todd A Wyatt; Peter J Oldenburg; Margaret K Elliott; William W West; Joseph H Sisson; Susanna G Von Essen; Debra J Romberger Journal: Am J Physiol Lung Cell Mol Physiol Date: 2009-04-24 Impact factor: 5.464